Analysis Treatment Guideline versus Clinical Practice Protocol in Patients Hospitalized due to Heart Failure

被引:0
作者
Correa, Alessandra da Graca [1 ]
Makdisse, Marcia [1 ]
Katz, Marcelo [1 ]
Santana, Thamires Campos [1 ]
Onaga Yokota, Paula Kiyomi [1 ]
Goncalves Galvao, Tatiana de Fatima [1 ]
Bacal, Fernando [1 ,2 ]
机构
[1] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Fac Med, Inst Coracao, BR-09500900 Sao Paulo, SP, Brazil
关键词
Heart Failure / therapy; Inpatients; Protocol; Quality Indicators; Health Care; PERFORMANCE-MEASURES; DISEASE MANAGEMENT; ACE-INHIBITOR; OUTCOMES; ASSOCIATION; CARVEDILOL; REGISTRY; CARMEN; ADHERE;
D O I
10.5935/abc.20160018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite the availability of guidelines for treatment of heart failure (HF), only a few studies have assessed how hospitals adhere to the recommended therapies. Objectives: Compare the rates of adherence to the prescription of angiotensin-converting enzyme inhibitor or angiotensin II receptor blockers (ACEI/ARB) at hospital discharge, which is considered a quality indicator by the Joint Commission International, and to the prescription of beta-blockers at hospital discharge, which is recommended by national and international guidelines, in a hospital with a case management program to supervise the implementation of a clinical practice protocol (HCP) and another hospital that follows treatment guidelines (HCG). Methods: Prospective observational study that evaluated patients consecutively admitted to both hospitals due to decompensated HF between August 1st, 2006, and December 31st, 2008. We used as comparing parameters the prescription rates of beta-blockers and ACEI/ARB at hospital discharge and in-hospital mortality. Results: We analyzed 1,052 patients (30% female, mean age 70.6 +/- 14.1 years), 381 (36%) of whom were seen at HCG and 781 (64%) at HCP. The prescription rates of beta-blockers at discharge at HCG and HCP were both 69% (p = 0.458), whereas those of ACEI/ARB were 83% and 86%, respectively (p = 0.162). In-hospital mortality rates were 16.5% at HCP and 27.8% at HCG (p < 0.001). Conclusion: There was no difference in prescription rates of beta-blocker and ACEI/ARB at hospital discharge between the institutions, but HCP had lower in-hospital mortality. This difference in mortality may be attributed to different clinical characteristics of the patients in both hospitals.
引用
收藏
页码:210 / 216
页数:7
相关论文
共 21 条
  • [1] Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications
    Ahmed, A
    Kiefe, CI
    Allman, RM
    Sims, RV
    DeLong, JF
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (10) : 1659 - 1666
  • [2] [Anonymous], HEART DIS STROK STAT
  • [3] Bocchi EA, 2012, ARQ BRAS CARDIOL, V98, P1, DOI 10.1590/S0066-782X2012000700001
  • [4] Adherence to heart failure quality-of-care indicators in US hospitals - Analysis of the ADHERE Registry
    Fonarow, GC
    Yancy, CW
    Heywood, JT
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (13) : 1469 - 1477
  • [5] Association between performance measures and clinical outcomes for patients hospitalized with heart failure
    Fonarow, Gregg C.
    Abraham, William T.
    Albert, Nancy M.
    Stough, Wendy Gattis
    Gheorghiade, Mihai
    Greenberg, Barry H.
    O'Connor, Christopher M.
    Pieper, Karen
    Sun, Jie Lena
    Yancy, Clyde
    Young, James B.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (01): : 61 - 70
  • [6] Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE)
    Fonarow, Gregg C.
    Heywood, J. Thomas
    Heidenreich, Paul A.
    Lopatin, Margarita
    Yancy, Clyde W.
    [J]. AMERICAN HEART JOURNAL, 2007, 153 (06) : 1021 - 1028
  • [7] The role of cardiac registries in evidence-based medicine
    Gitt, Anselm K.
    Bueno, Hector
    Danchin, Nicolas
    Fox, Kevin
    Hochadel, Matthias
    Kearney, Peter
    Maggioni, Aldo P.
    Opolski, Grzegorz
    Seabra-Gomes, Ricardo
    Weidinger, Franz
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 (05) : 525 - U9
  • [8] Instituto do Coracao. Hospital de Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, 2010, REL GEST I COR 2010
  • [9] JointCommission International, 2008, JOINT COMM INT ACCR
  • [10] Tolerability of carvedilol and ACE-inhibition in mild heart failure.: Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN)
    Komajda, M
    Lutiger, B
    Madeira, H
    Thygesen, K
    Bobbio, M
    Hildebrandt, P
    Jaarsma, W
    Riegger, G
    Rydén, L
    Scherhag, A
    Soler-Soler, J
    Remme, WJ
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (04) : 467 - 475